Afasevikumab - HY-P99424
Nur noch %1 verfügbar
Catalog #
HY-P99424
Ab
310,00 €
Afasevikumab (RG 7624; RO 5553110; NI-1401) is a fully human monoclonal IgG1κ antibody neutralizing both IL-17A and IL-17F. Afasevikumab has anti-inflammatory activities[1].
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-P99424/Afasevikumab-DataSheet-MedChemExpress.pdf |
|---|---|
| Shipping | Dry Ice |
| Application | COVID-19-immunoregulation |
| Alternative Names | RG 7624; RO 5553110; NI-1401 |
| CAS | 1589503-30-9 |
| Storage | Store at -80°C for 2 years |
| MWT | (146.065 kDa) |
| Solubility | 10 mM in DMSO |
| Clinical Information | No Development Reported |
| Target | Interleukin Related |
| Application: | COVID-19-immunoregulation |
|---|